Atara Biotherapeutics $ATRA develops next-gen #CART therapies & off-the-shelf allogeneic #TCellRx #immunotherapy for cancer & #MS #EBV #PTLD #celltherapy
Joined July 2017
- Tweets 707
- Following 1,163
- Followers 2,042
- Likes 957
524 Photos and videos
Today we announced our first quarter 2024 financial results and operational progress. The latest news is available here: bit.ly/4adw4rd
#celltherapy #allogeneic #CART $ATRA
1
13
1,833
Today we announced our fourth quarter and full year 2023 operational progress and financial results. The latest news is available here: bit.ly/4acaYKD
#celltherapy #allogeneic #CART $ATRA
68
1
9
1,718
Tune in now for a cell therapy panel with CEO Pascal Touchon at Cowen Inc.’s 44th Annual Healthcare Conference. A link to the live webcast can be found in the investor section of our website: lnkd.in/gFWidVC7
63
7
1,299
We are excited to announce that Atara’s Investigational New Drug application for ATA3219, our investigational, allogeneic, anti-CD19 #CAR #Tcell therapy, has received FDA clearance in systemic lupus erythematosus (#SLE) with #lupusnephritis. Read more: bit.ly/3UTAZK0
10
1
11
1,229
It was a pleasure highlighting the latest developments and potential of Atara's #allogeneic #CART programs for hematological malignancies and autoimmune diseases at #JPM24. bit.ly/3vxNksE
2
2
14
1,392
Next week, our CEO Pascal Touchon is heading to San Francisco to share Atara's latest pipeline progress & key development milestones at the J.P. Morgan Annual Healthcare Conference on Thursday, January 11 at 9:45 a.m. PT: bit.ly/3H8hXrd
#CART #JPM24
5
11
1,026
At this year's @ASH_hematology Annual Meeting, Atara will present positive preclinical data on ATA3431, our investigational next-generation #allogeneic CD20/CD19-targeted #CAR #EBV T-cell therapy for the treatment of B-cell malignancies. For more: bit.ly/3GA8b0O #ASH23
1
3
14
1,456
We’re heading to San Diego for #ASH23 to share positive new preclinical B-cell malignancy data for ATA3431, an investigational next-generation #allogeneic CD20/CD19-targeted CAR #EBV T-cell therapy. Be sure to stop by and check out our poster on Dec. 11.
3
2
10
1,240
Happening today, we are joining @myESMO to present new data from a combined analysis evaluating tab-cel® for #EBV CNS #PTLD during an oral session. Learn more: bit.ly/413hsYp #ESMOImmuno23
1
6
995
We're gearing up to join researchers and clinicians at #ESMOImmuno23. We look forward to presenting new clinical data during an oral session evaluating investigational tab-cel® for #EBV CNS #PTLD. Learn more: bit.ly/3GllVw7
4
818
Today we announced Atara entered an expanded global tab-cel® partnership with Pierre Fabre Laboratories. Tune in to our conference call and live webcast at 9:00 a.m. EDT to hear more and other third quarter 2023 corporate updates. bit.ly/45WNUga
#EBV #MS #CART #PTLD
2
2
8
1,393
While autologous T-cell therapies have been life-changing for many patients, allogeneic approaches hold the promise of personalized, off-the-shelf treatments manufactured at scale, stored and ready for rapid delivery. Learn more about Atara’s approach: bit.ly/3CrLs50
1
8
920
Atara’s EBV T-cell platform has the potential to address a wide range of EBV-driven diseases or other serious diseases through the incorporation of engineered #CARs. Learn more about our versatile platform: bit.ly/3CrLs50
1
4
784
Today, our CSO & CTO, Cokey Nguyen, joins @alliancerm's #CGMesa23 to discuss how the world’s first-ever approval of an allogeneic T-cell therapy helped galvanize the #celltherapy field, paving the way to make further inroads into our fight against cancer and autoimmune disorders.
1
8
813
On #WorldMentalHealthDay, we emphasize our commitment to promoting mental well-being within our organization and beyond. Our Spring Health Mental Wellness Benefit empowers Atarians with the resources to focus on our mission of developing therapies to transform patients' lives.
2
535
At Atara, we are using allogeneic Epstein-Barr virus (#EBV) T cells as a platform to develop investigational therapies for cancer and autoimmune diseases. Learn more about our pipeline: bit.ly/3qq01Um
1
4
604
Everything we do at Atara revolves around our mission to transform patients' lives. On #RareCancerDay, we join @RareDiseases and this resilient community to honor those affected by uncommon #cancers and shed light on the challenges faced by people living with #rarecancers.
5
503
Allogeneic cell therapies can be stored in advance of patient need, ready for delivery within days. Learn more about our off-the-shelf approach: bit.ly/3fhXndG
5
518
Congrats to Atara's Meegan Kerman, an award recipient for @SFVBJ's Women's Leadership Symposium's ‘Woman to Watch’ category! Meegan helps equip Atarians with tools to better balance personal commitments and professional growth, fostering lifelong learning and development.
4
571